Hiroshi Yokouchi

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

Hajime Asahina, K Yamazaki, Ichiro Kinoshita et al. · British Journal of Cancer · 2006 · 278 citations · Full text

Medicine, Oncology, Pharmacology +14

Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402

Akira Inoue, Shunichi Sugawara, Koichi Yamazaki et al. · Journal of Clinical Oncology · 2008 · 235 citations

Medicine, Oncology, Pharmacology +11

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation

Masahiko Higashiyama, Osamu Doi, Ken Kodama et al. · British Journal of Cancer · 1997 · 135 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Clinical characteristics of pleomorphic carcinoma of the lung

Kenichiro Ito, Satoshi Oizumi, Shinichi Fukumoto et al. · Lung Cancer · 2009 · 131 citations · Full text

Medicine, Oncology, Pathology +13

GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets

Paul A. Insel, Krishna Sriram, Shu Z. Wiley et al. · Frontiers in Pharmacology · 2018 · 131 citations · Full text

Medicine, Molecular Biology, Oncology +16